Atezolizumab,vinorelbine
roche
['nsclc', 'platinum', 'sclc', 'tecentriq', 'roche,(-broche),(-rocheter)']
roche aims solo tecentriq at the over 40% of advanced nsclc patients with poor performance status or are elderly people with multiple comorbidities who can t tolerate platinum-based chemo. #esmo22 
Tweets from the Fierce Life Sciences editorial team